Sanofi fabrazyme?

What is Sanofi Fabrazyme?

Fabrazyme is the brand name for agalsidase beta, an enzyme replacement therapy used to treat Fabry disease. Fabrazyme is made by Sanofi.

What is Fabrazyme used for in Fabry disease?

Fabrazyme is used to treat the underlying enzyme deficiency in Fabry disease by replacing the defective enzyme that the body lacks. This is intended to help manage disease manifestations linked to Fabry disease.

Who makes Fabrazyme (Sanofi)?

The product is marketed under the Fabrazyme name by Sanofi (agalsidase beta / enzyme replacement therapy).

Are there patents or exclusivity issues around Fabrazyme?

For the latest patent and exclusivity status tied to Fabrazyme (agalsidase beta) and related filings, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/

What do people commonly look up next?

Common follow-up searches include:
- dosing and administration (infusion schedule and setting)
- side effects and infusion-related reactions
- how it compares with other Fabry enzyme therapies (e.g., enzyme alternatives made by different manufacturers)
- whether generic or biosimilar alternatives exist or when they could enter

Sources

• https://www.drugpatentwatch.com/